RxDoctor Payments Data

Gene Campbell, MD

Family Medicine · Pierre, SDNPI 1740778661

Payments from drug & device makers

$1,079in general payments, 2019–2025

Across 59 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$227
  • Lilly USA, LLC$165
  • Novo Nordisk$158
  • Biohaven Pharmaceutical Holding Company Ltd.$81
  • Boehringer Ingelheim$81
  • E.r. Squibb & Sons, L.L.C.$67
  • plus $299 from 10 others

What the payments were for

  • Food & beverage$1,079100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,079 in reported general payments places this provider in the 80th percentile of 408 family medicine providers in South Dakota.

See all family medicine providers in South Dakota

Medicare billing

Part B allowed, 2024
$129,222
Medicare patients
370
Services billed
2,688

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide91$98,858
JardianceEmpagliflozin50$65,016
EliquisApixaban44$50,652
FarxigaDapagliflozin Propanediol30$28,582
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$16,540
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$14,113
JanuviaSitagliptin Phosphate12$10,763
Tresiba Flextouch U-200Insulin Degludec11$8,455
XareltoRivaroxaban13$8,174
Tresiba Flextouch U-100Insulin Degludec15$7,861
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$4,485
Ezetimibe65$1,868
Atorvastatin Calcium298$1,863
SynthroidLevothyroxine Sodium24$1,632
Omeprazole171$1,624

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$158$98,85891 claims
Boehringer IngelheimJardiance$81$65,01650 claims
PfizerEliquis$17$50,65244 claims
AstraZenecaFarxiga$16$28,58230 claims
MerckJanuvia$18$10,76312 claims
Johnson & JohnsonXarelto$63$8,17413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 408 family medicine providers in South Dakota.

Other family medicine in Pierre

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →